Prelude therapeutics announces participation at three upcoming virtual investor conferences

Wilmington, del., march 03, 2021 (globe newswire) -- prelude therapeutics inc. (“prelude”, “the company”, “we”, “our”) (nasdaq: prld), a clinical-stage precision oncology company, today announced that members of its management team will participate in three upcoming virtual investor conferences:
PRLD Ratings Summary
PRLD Quant Ranking